<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   3683
  </number>
  <updateDate>
   2022-12-30T17:32:57Z
  </updateDate>
  <updateDateIncludingText>
   2022-12-30T17:32:57Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-06-01
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 95 (Tuesday, June 1, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. STAUBER:H.R. 3683.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8.[Page H2686]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hswm00
    </systemCode>
    <name>
     Ways and Means Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hswm04
      </systemCode>
      <name>
       Trade Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-06-01T20:40:07Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-06-01T19:02:30Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hsgo00
    </systemCode>
    <name>
     Oversight and Accountability Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-06-01T19:02:25Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <actions>
   <item>
    <actionDate>
     2021-06-01
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hswm04
      </systemCode>
      <name>
       Trade Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Trade.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-06-01
    </actionDate>
    <text>
     Referred to the Committee on Oversight and Reform, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hswm00
      </systemCode>
      <name>
       Ways and Means Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-06-01
    </actionDate>
    <text>
     Referred to the Committee on Oversight and Reform, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsgo00
      </systemCode>
      <name>
       Oversight and Accountability Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-06-01
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-06-01
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     S001212
    </bioguideId>
    <fullName>
     Rep. Stauber, Pete [R-MN-8]
    </fullName>
    <firstName>
     Pete
    </firstName>
    <lastName>
     Stauber
    </lastName>
    <party>
     R
    </party>
    <state>
     MN
    </state>
    <district>
     8
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     G000559
    </bioguideId>
    <fullName>
     Rep. Garamendi, John [D-CA-3]
    </fullName>
    <firstName>
     John
    </firstName>
    <lastName>
     Garamendi
    </lastName>
    <party>
     D
    </party>
    <state>
     CA
    </state>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-06-01
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Government Operations and Politics
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects/>
   <policyArea>
    <name>
     Government Operations and Politics
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-06-01
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-07-23T19:13:52Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Securing America's Pharmaceutical Supply Chain Act&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill allows an executive agency to purchase a drug approved or licensed by the Food and Drug Administration only if the drug is over 50% sourced, manufactured, and assembled in the United States.&lt;/p&gt; &lt;p&gt;This requirement may be waived (1) if the drug is not available in sufficient quantity or quality as over 50% sourced, manufactured, and assembled in the United States; or (2) during an emergency.&lt;/p&gt; &lt;p&gt;The U.S. Trade Representative (USTR) shall modify U.S. product coverage under all free trade agreements and the World Trade Organization Agreement on Government Procurement to exclude coverage of essential medicines and medical countermeasures. Subsequent to such modifications, the USTR shall make any necessary corresponding modifications of existing waivers and notify the Office of Management and Budget.&lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Securing America’s Pharmaceutical Supply Chain Act
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Securing America’s Pharmaceutical Supply Chain Act
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To require executive agencies to purchase pharmaceuticals from the United States, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Securing America’s Pharmaceutical Supply Chain Act
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-06-01T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr3683ih/xml/BILLS-117hr3683ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-06-01
   </actionDate>
   <text>
    Referred to the Subcommittee on Trade.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-06-01
Trade Subcommittee
hswm04
1
House committee actions
Referred to the Subcommittee on Trade.
Committee
H11100
2021-06-01
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Oversight and Reform, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-06-01
Oversight and Accountability Committee
hsgo00
2
House floor actions
Referred to the Committee on Oversight and Reform, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-06-01
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-06-01
9
Library of Congress
Introduced in House
IntroReferral
2021-06-01T19:02:30Z
Referred to
House
Ways and Means Committee
2021-06-01T20:40:07Z
Referred to
Trade Subcommittee
hswm04
hswm00
Standing
2021-06-01T19:02:25Z
Referred to
House
Oversight and Accountability Committee
hsgo00
Standing
G000559
3
John
Rep. Garamendi, John [D-CA-3]
Garamendi
D
2021-06-01
CA
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-06-01
2021-06-01
Referred to the Subcommittee on Trade.
House
Government Operations and Politics
S001212
8
Pete
Rep. Stauber, Pete [R-MN-8]
N
Stauber
R
MN
2021-06-01
Introduced in House
 <p><b>Securing America's Pharmaceutical Supply Chain Act</b></p> <p>This bill allows an executive agency to purchase a drug approved or licensed by the Food and Drug Administration only if the drug is over 50% sourced, manufactured, and assembled in the United States.</p> <p>This requirement may be waived (1) if the drug is not available in sufficient quantity or quality as over 50% sourced, manufactured, and assembled in the United States; or (2) during an emergency.</p> <p>The U.S. Trade Representative (USTR) shall modify U.S. product coverage under all free trade agreements and the World Trade Organization Agreement on Government Procurement to exclude coverage of essential medicines and medical countermeasures. Subsequent to such modifications, the USTR shall make any necessary corresponding modifications of existing waivers and notify the Office of Management and Budget.</p>
2021-07-23T19:13:52Z
00
2021-06-01T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr3683ih/xml/BILLS-117hr3683ih.xml
Securing America’s Pharmaceutical Supply Chain Act
Securing America’s Pharmaceutical Supply Chain Act
Display Title
IH
Introduced in House
To require executive agencies to purchase pharmaceuticals from the United States, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Securing America’s Pharmaceutical Supply Chain Act
Short Title(s) as Introduced
HR
2022-12-30T17:32:57Z
2022-12-30T17:32:57Z
3.0.0
2021-06-01
Trade Subcommittee
hswm04
1
House committee actions
Referred to the Subcommittee on Trade.
Committee
H11100
2021-06-01
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Oversight and Reform, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-06-01
Oversight and Accountability Committee
hsgo00
2
House floor actions
Referred to the Committee on Oversight and Reform, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-06-01
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-06-01
9
Library of Congress
Introduced in House
IntroReferral
S001212
8
Pete
Rep. Stauber, Pete [R-MN-8]
N
Stauber
R
MN
G000559
3
John
Rep. Garamendi, John [D-CA-3]
Garamendi
D
2021-06-01
CA
2021-06-01
Introduced in House
 <p><b>Securing America's Pharmaceutical Supply Chain Act</b></p> <p>This bill allows an executive agency to purchase a drug approved or licensed by the Food and Drug Administration only if the drug is over 50% sourced, manufactured, and assembled in the United States.</p> <p>This requirement may be waived (1) if the drug is not available in sufficient quantity or quality as over 50% sourced, manufactured, and assembled in the United States; or (2) during an emergency.</p> <p>The U.S. Trade Representative (USTR) shall modify U.S. product coverage under all free trade agreements and the World Trade Organization Agreement on Government Procurement to exclude coverage of essential medicines and medical countermeasures. Subsequent to such modifications, the USTR shall make any necessary corresponding modifications of existing waivers and notify the Office of Management and Budget.</p>
2021-07-23T19:13:52Z
00
Securing America’s Pharmaceutical Supply Chain Act
Securing America’s Pharmaceutical Supply Chain Act
Display Title
IH
Introduced in House
To require executive agencies to purchase pharmaceuticals from the United States, and for other purposes.
Official Title as Introduced
IH
Introduced in House
Securing America’s Pharmaceutical Supply Chain Act
Short Title(s) as Introduced
2021-06-01
Referred to the Subcommittee on Trade.